Home › NDC Lookup › Ingredients › Phenylephrine Hydrochloride › 70000-0132-01
👃image loading
(from DailyMed)

Extra Strength Sinus Relief Nasal Decongestant Phenylephrine Hydrochloride 1 g/100mL Spray — NDC 70000-0132-1 (Billing 70000-0132-01)

by CARDINAL HEALTH · 1 BOTTLE, SPRAY in 1 CARTON / 30 mL in 1 BOTTLE, SPRAY

This is a package of Extra Strength Sinus Relief Nasal Decongestant Phenylephrine Hydrochloride 1 g/100mL Spray from CARDINAL HEALTH, marketed since Jun 2017 and currently FDA-listed; retail pharmacies pay about $0.0703 per mL (NADAC). It is this product's only package size.

NDC 70000-0132-01
🏷️ FDA NDC (as labeled) 70000-0132-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70000-0132-1
Product NDC 70000-0132
11-digit billing NDC 70000013201
NCPDP billing unit ML — per mL (volume)
RxCUI 1087043
UNII 04JA59TNSJ
Application # M012
SPL Set ID 0d8a009c-30b5-4f12-90bd-f8aa1110243f
Established class (EPC) alpha-1 Adrenergic Agonist
Mechanism of action Adrenergic alpha1-Agonists
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2017-06-06
Route NASAL
Dosage form SPRAY
Substance PHENYLEPHRINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 42102050102015
GPI class Sinus Relief Extra Strength
GCN Seq No 008062
GCN 34124
HICL code 002087
Ingredient (HICL) Phenylephrine Hcl
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q7
Therapeutic class — intermediate (HIC2) Nasal Preparations
HIC3 code Q7D
Therapeutic class — specific (HIC3) Nose Preparations, Vasoconstrictors(Otc)
AHFS code 12:12.04.00
AHFS class Alpha-Adrenergic Agonists (12:12)
FDB label name SINUS RELIEF 1% NASAL SPRAY
FDB brand name Sinus Relief
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 008062
  • GCN: 34124
  • GPI-14 (Medi-Span): 42102050102015
  • HICL (First Databank): 002087
  • AHFS class code: 12:12.04.00
  • RxCUI (RxNorm): 1087043
Why two NDCs? The FDA registers this code as 70000-0132-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0132-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the alpha-1 Adrenergic Agonist class.

Pharmacologic class alpha-1 Adrenergic Agonist
Drug family (ATC) Sympathomimetics excl. antiglaucoma preparations, Adrenergic and dopaminergic agents, Other agents for treatment of hemorrhoids and anal fissures for topical use
How it works Adrenergic alpha1-Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name SINUS RELIEF 1% NASAL SPRAY Ingredient Phenylephrine Hcl
📗 Our plain-language guide HelloPharmacist
  • It depends on the product. The injection raises low blood pressure during anesthesia and, for some products, septic shock. Eye drops dilate the pupil, nasal products relieve conges...
  • Be careful. Over-the-counter phenylephrine should not be used with a prescription MAOI or within 2 weeks of stopping one. If you aren't sure whether your medicine is an MAOI, ask m...
  • With the injection, the most common are nausea, vomiting and headache. Call for help right away if you have chest pain, a very slow heartbeat, or pain or skin changes around the IV...
  • Stop and talk to a doctor if you get nervousness, dizziness or sleeplessness. Also stop if symptoms last more than 7 days or come with a fever. Don't use more than the label recomm...
📖 Read our full Phenylephrine guide →

Supplement & herbal interactions

Some supplements/herbs that may interact with Phenylephrine Hydrochloride — tap one for details:

Butcher's BroomModerate
🌿 Every supplement checked against Phenylephrine Hydrochloride (1 interactions) — ranked by severity →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.070 $2.11 / 30 ml
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Sep 2021 Jan 2026 May 2026 Sep 2026 $0.070 $0.062
▲ Up 14% over the last 13 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70000-0132-01 You're viewing this Main listing 1 BOTTLE, SPRAY in 1 CARTON / 30 mL in 1 BOTTLE, SPRAY 2017-06-06 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Sense Nasal Four 1 g/100mL 00113-0648-10 L. 1 bottle $0.067 — Availability likely save 4%
Extra Strength Sinus Relief Nasal Decongestant 1 g/100mLthis 70000-0132-01 CARDINAL 1 bottle $0.070 — Availability likely —
Quality Choice 1 g/100mL 83324-0215-01 CHAIN 1 bottle $0.070 — Availability likely —
good neighbor pharmacy nasal four 1 g/100mL 46122-0689-03 Amerisource 1 bottle $0.084 — Availability likely +20%
4 Way Fast Acting 10 mg/mL 00067-2086-01 Haleon 1 bottle — — FDA listed —
Neo-Synephrine Maximum 1 g/100mL 00225-0810-47 BF 15 ml — — FDA listed —
Neo-Synephrine Severe 1 g/100mL 00225-0811-47 BF 15 ml — — FDA listed —
nasal 1 g/100mL 00363-0717-10 Walgreen 1 bottle — — FDA listed —
Better Living 1 g/100mL 21130-0728-30 BETTER 1 bottle — — FDA listed —
nasal 1 g/100mL 30142-0539-10 Kroger 1 bottle — — FDA listed —
Topcare Nasal Four 1 g/100mL 36800-0648-10 Topco 1 bottle — — FDA listed —
heb nasal 1 g/100mL 37808-0728-30 H 1 bottle — — FDA listed —
equaline nasal 1 g/100mL 41163-0648-10 United 1 bottle — — FDA listed —
Publix 1 g/100mL 41415-0728-30 PUBLIX 1 bottle — — FDA listed —
CareOne Fast Acting Nasal 1 g/100mL 41520-0729-10 American 1 bottle — — FDA listed —
Nasal Four 1 g/100mL 42507-0648-10 HyVee 1 bottle — — FDA listed —
Equate Nasal 1 g/100mL 49035-0648-10 Wal-Mart 1 bottle — — FDA listed —
No Drip Nasal 10 mg/mL 51316-0648-10 CVS 1 bottle — — FDA listed —
dg health nasal four 1 g/100mL 55910-0802-10 Dolgencorp, 1 bottle — — FDA listed —
Dollar General 1 g/100mL 55910-0827-30 DOLGENCORP, 1 bottle — — FDA listed —
CVS Health Four Actions Nasal Decongestant 10 mg/mL 59779-0838-30 CVS 1 bottle — — FDA listed —
Quality Choice 1 g/100mL 63868-0697-30 CHAIN 1 bottle — — FDA listed —
Extra Strength Nasal 1 g/100mL 69842-0443-30 CVS 1 bottle — — FDA listed —
Nasal 1 g/100mL 69842-0648-10 CVS 1 bottle — — FDA listed —
basic care nasal 1 g/100mL 72288-0648-10 Amazon.com 1 bottle — — FDA listed —
Nasal 1 g/100mL 79481-0101-00 Meijer, 1 bottle — — FDA listed —
Equate Nasal 10 mg/mL 79903-0276-01 WALMART 1 bottle — — FDA listed —
Ephrine Nose Drops 1 g/100mL 00363-2023-10 Walgreens 1 bottle — — FDA listed —
Nasal 1 g/100mL 72288-0742-10 Amazon.com 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2017
On the market since
Jun 2017
📍
2026
Currently FDA-listed
9 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCARDINAL HEALTH
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code70000
First marketedJun 2017
Product typeHuman Otc Drug
Portfolio84 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 50 words ▾

Uses temporarily relieves nasal congestion: due to common cold due to hay fever or other upper respiratory allergies (allergic rhinitis) temporarily relieves stuffy nose. helps clear nasal passages; shrinks swollen membranes temporarily restores freer breathing through the nose helps decongest sinus openings and passages; temporarily relieves sinus congestion and pressure

⏱️ Dosage and Administration 40 words ▾

Directions Use only as directed to spray, squeeze bottle quickly and firmly adults and children 12 years older: 2 or 3 sprays in each nostril not more often than every 4 hours. children under 12 years : ask a doctor

⚠️ Warnings 20 words ▾

Warnings Do Not Use If you have ever had an allergic reaction to this product or any of its ingredients

📦 Storage and Handling 9 words ▾

Other information store at room temperature Protect from light.

🧪 Active Ingredient 6 words ▾

Active ingredients Phenylephrine Hydrochloride 1.0 %

🧪 Inactive Ingredients 17 words ▾

Inactive ingredients anhydrous citric acid, benzalkonium chloride, benzyl alcohol, purified water, sodium chloride, sodium citrate Questions 1-866-467-2748

🎯 Purpose 3 words ▾

Purpose Nasal decongestant

📄 Do Not Use 19 words ▾

Do Not Use If you have ever had an allergic reaction to this product or any of its ingredients

📄 Ask a Doctor Before Use If 34 words ▾

Ask a doctor before use if you have heart disease high blood pressure thyroid disease diabetes trouble urinating due to an enlarged prostate gland difficulty in urination due to enlargement of the prostate gland

📄 When Using This Product 59 words ▾

When using this product do not exceed recommended dosage do not use for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen temporary discomfort may occur such as burning, stinging, sneezing and increase in nasal discharge use of this container by more than one person may spread infection

📄 Stop Use and Ask a Doctor If 14 words ▾

Stop use and ask a doctor if symptoms persist for more than 3 days.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding ask a health professional before use.

📄 Keep Out of Reach of Children 20 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away 1-800-222-1222

📄 Questions or Comments 2 words ▾

Questions 1-866-467-2748

📄 Package Label / Principal Display Panel 153 words ▾

Principal Display LEADER NDC 70000-0132-1 COMPARE TO NEO-SYNEPHRINE ® EXTRA STRENGTH active ingredient Extra Strength Sinus Relief Phenylephrine hydrochloride 1.0 % Nasal Decongestant Fast Relief Of: Sinus Congestion & Pressure Colds, Allergies 1 FL OZ (30 mL) * This product is not manufactured or distributed by Foundation Consumer Healthcare LLC owner of the registered trademark Neo-Synephrine ® Extra Strength. IMPORTANT: Keep this carton for future reference on full labeling. Do not use if printed seal over cap is torn or missing ©2017 Cardinal Health, All Rights Reserved , CARDINAL HEALTH ,the Cardinal Health LOGO, LEADER, and the Leader LOGO are trademarks or registered trademarks of Cardinal Health.

Cardinal Health™ DISTRIBUTED BY CARDINAL HEALTH DUBLIN, OHIO 43017 www.myleader.com 1-800-200-6313 Essential to care™ since 1979 * This product is not manufactured or distributed by Foundation Consumer Healthcare LLC owner of the registered trademark Neo-Synephrine ® Extra Strength. LEADER Extra Strength Sinus Relief 1 FL OZ

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by CARDINAL HEALTH. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
CARDINAL HEALTH is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 70000-0127-01 · Cardinal 70000-0133-01 · Cardinal →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.